In this Product Explainer, Urologist Dr Jeff Thavaseelan discusses the role of mirabegron in overactive bladder management, including its mechanism of action, safety profile, treatment positioning, and practical considerations for patient selection and referral (6 mins).

Astellas Pharma Australia Pty Ltd Suite 2.01, 2 Banfield Rd, Macquarie Park NSW 2113.
MAT-AU-BET-2026-00053 – August 2026